Table of Contents

• Mariko Watanabe,
• Kazue Yamaoka,
• Masako Yokotsuka,
• and Toshiro Tango

Randomized Controlled Trial of a New Dietary Education Program to Prevent Type 2 Diabetes in a High-Risk Group of Japanese Male Workers

• Alam Khan,
• Mahpara Safdar,
• Mohammad Muzaffar Ali Khan,
• Khan Nawaz Khattak,
• and Richard A. Anderson

Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes

• Anthony J.G. Hanley,
• Philip W. Connelly,
• Stewart B. Harris,
• and Bernard Zinman

Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition

• Chamukuttan Snehalatha,
• Bheekamchand Mukesh,
• Mary Simon,
• Vijay Viswanathan,
• Steven M. Haffner,
• and Ambady Ramachandran

Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians

• Jaana Lindström,
• Anne Louheranta,
• Marjo Mannelin,
• Merja Rastas,
• Virpi Salminen,
• Johan Eriksson,
• Matti Uusitupa,
• and Jaakko Tuomilehto

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity

Additional information for this article can be found in an online appendix at http://care.diabetesjournals.org.

A table elsewhere in this issue shows conventional and Systéme International (SI) units and conversion factors for many substances.

• Carolyn M. Fronczak,
• Anna E. Barón,
• H. Peter Chase,
• Colleen Ross,
• Heather L. Brady,
• Michelle Hoffman,
• George S. Eisenbarth,
• Marian Rewers,
• and Jill M. Norris

In Utero Dietary Exposures and Risk of Islet Autoimmunity in Children

• Michael G. Masding,
• Anna J. Stears,
• Graham C. Burdge,
• Stephen A. Wootton,
• and Derek D. Sandeman

Premenopausal Advantages in Postprandial Lipid Metabolism Are Lost in Women With Type 2 Diabetes

• A. Marshall McBean,
• Zhen Huang,
• Beth A. Virnig,
• Nicole Lurie,
• and Dorothea Musgrave

Racial Variation in the Control of Diabetes Among Elderly Medicare Managed Care Beneficiaries

• Nathalie de Rekeneire,
• Helaine E. Resnick,
• Ann V. Schwartz,
• Ronald I. Shorr,
• Lewis H. Kuller,
• Eleanor M. Simonsick,
• Bruno Vellas,
• and Tamara B. Harris

Diabetes Is Associated With Subclinical Functional Limitation in Nondisabled Older Individuals: The Health, Aging, and Body Composition study

• Michele Sacco,
• Fabio Pellegrini,
• Maria C. Roncaglioni,
• Fausto Avanzini,
• Gianni Tognoni,
• and Antonio Nicolucci

Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients: Results of the Primary Prevention Project (PPP) trial

• Mikael Kjær Poulsen,
• Jan Erik Henriksen,
• Ole Hother-Nielsen,
• and Henning Beck-Nielsen

The Combined Effect of Triple Therapy With Rosiglitazone, Metformin, and Insulin Aspart in Type 2 Diabetic Patients

• Lalita Khaodhiar,
• James B. Niemi,
• Russell Earnest,
• Christina Lima,
• Jason D. Harry,
• and Aristidis Veves

Enhancing Sensation in Diabetic Neuropathic Foot With Mechanical Noise

• David G. Armstrong,
• Lawrence A. Lavery,
• Jefferey R. Vazquez,
• Brian Short,
• Heather R. Kimbriel,
• Brent P. Nixon,
• and Andrew J.M. Boulton

Clinical Efficacy of the First Metatarsophalangeal Joint Arthroplasty as a Curative Procedure for Hallux Interphalangeal Joint Wounds in Patients with Diabetes

• Boaz Hirshberg,
• Kristina I. Rother,
• Benigno J. Digon III,
• Janet Lee,
• Jason L. Gaglia,
• Kenneth Hines,
• Elizabeth J. Read,
• Richard Chang,
• Bradford J. Wood,
• and David M. Harlan

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• Steen Andersen,
• Jens Bröchner-Mortensen,
• and Hans-Henrik Parving

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria

• Patricia Blackburn,
• Benoît Lamarche,
• Charles Couillard,
• Agnés Pascot,
• Angelo Tremblay,
• Jean Bergeron,
• Isabelle Lemieux,
• and Jean-Pierre Després

Contribution of Visceral Adiposity to the Exaggerated Postprandial Lipemia of Men With Impaired Glucose Tolerance

• Paresh Dandona,
• Ahmad Aljada,
• Priya Mohanty,
• Husam Ghanim,
• Arindam Bandyopadhyay,
• and Ajay Chaudhuri

Insulin Suppresses Plasma Concentration of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9

• Norbert Stefan,
• Michael Stumvoll,
• Barbora Vozarova,
• Christian Weyer,
• Tohru Funahashi,
• Yuji Matsuzawa,
• Clifton Bogardus,
• and P. Antonio Tataranni

Plasma Adiponectin and Endogenous Glucose Production in Humans

• Juan F. Ascaso,
• Susana Pardo,
• José T. Real,
• Rosario I. Lorente,
• Antonia Priego,
• and Rafael Carmena

Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism

• Desmond Schatz,
• Edwin A.M. Gale,
• and Mark A. Atkinson

Why Can’t We Prevent Type 1 Diabetes?: Maybe it’s time to try a different combination

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

• Mayer B. Davidson,
• Pamela B. Landsman,
• and Charles M. Alexander

Lowering the Criterion for Impaired Fasting Glucose Will Not Provide Clinical Benefit

• Saul Genuth

Lowering the Criterion for Impaired Fasting Glucose Is in Order

Peripheral Arterial Disease in People With Diabetes

• Zachary T. Bloomgarden

Approaches to Cardiovascular Disease and Its Treatment

• John A. Colwell

Aspirin for Primary Prevention of Cardiovascular Events in Diabetes

• Chin-Hsiao Tseng

Prevalence and Risk Factors of Diabetic Foot Problems in Taiwan: A cross-sectional survey of non-type 1 diabetic patients from a nationally representative sample

• Daad H. Akbar and
• Abeer H. Kawther

Nonalcoholic Fatty Liver Disease in Saudi Type 2 Diabetic Subjects Attending a Medical Outpatient Clinic: Prevalence and general characteristics

• Ian W. Gallen and
• Celia Carter

Prospective Audit of the Introduction of Insulin Glargine (Lantus) Into Clinical Practice in Type 1 Diabetic Patients

• Deb K. Bjorsness,
• Philip A. Krezowski,
• Todd S. Harwell,
• Janet M. McDowall,
• Marcene K. Butcher,
• Steven D. Helgerson,
• and Dorothy Gohdes

Self-Blood Glucose Monitoring Practices: Do patients know and act on their target?

D.G. has received honoraria or consulting fees from NovoNordisk, Aventis, and GlaxoSmithKline.

• Dong-Jun Kim,
• Kwang-Won Kim,
• Nam-Han Cho,
• Jung-Hyun Noh,
• Myung-Shik Lee,
• and Moon-Kyu Lee

The Cutoff Value of Fasting Plasma Glucose to Differentiate Frequencies of Cardiovascular Risk Factors in a Korean Population

• Saleh A. Aldasouqi and
• Daniel S. Duick

Safety Issues on Metformin Use

• Stefan Lange,
• Curt Diehm,
• Harald Darius,
• Roman Haberl,
• Jens Rainer Allenberg,
• David Pittrow,
• Alexander Schuster,
• Berndt von Stritzky,
• Gerhart Tepohl,
• and Hans Joachim Trampisch

High Prevalence of Peripheral Arterial Disease but Low Antiplatelet Treatment Rates in Elderly Primary Care Patients With Diabetes

• Karen Zulkowski,
• Patricia Coon,
• and Charles Wittnam

Patient and Provider Congruence

• James McKinney,
• Henian Cao,
• Margaret T. Behme,
• Jeffrey L. Mahon,
• and Robert A. Hegele

Maturity-Onset Diabetes of the Young (MODY) Mutation in Type 2 Diabetes and Latent Autoimmune Diabetes of the Adult

• Robert C. Hood

It Can Be Done

• Keiji Yoshioka,
• Toshihide Yoshida,
• and Toshikazu Yoshikawa

Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: Response to Nagasaka et al.

• Shoichiro Nagasaka,
• Ataru Taniguchi,
• Yoshitaka Aiso,
• Toshimitsu Yatagai,
• Tomoatsu Nakamura,
• Yoshikatsu Nakai,
• Mitsuo Fukushima,
• Akira Kuroe,
• and Shun Ishibashi

Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: Response to Yoshioka, Yoshida, and Yoshikawa

• Michelle A. Baron

Comparison of Repaglinide and Nateglinide in Combination With Metformin: Response to Raskin et al.

M.A.B. holds stock in Novartis Pharmaceuticals, Pfizer, and Johnson & Johnson.

• Philip Raskin

Comparison of Repaglinide and Nateglinide in Combination With Metformin: Response to Baron

P.R. has served on an advisory panel for, has received consulting fees from, and has received grant/research support from Novo Nordisk.

• Jennie C. Brand-Miller,
• Peter Petocz,
• and Stephen Colagiuri

Meta-Analysis of Low–Glycemic Index Diets in the Management of Diabetes: Response to Franz

J.C.B.-M. is the director of GI Limited and of the Sydney University Glycemic Index Research Service (SUGiRS) and has received honoraria for speaking engagements on the glycemic index of foods.

• Jim Mann

Meta-Analysis of Low-Glycemic Index Diets in the Management of Diabetes: Response to Franz

• Marion J. Franz

Meta-Analysis of Low-Glycemic Index Diets in the Management of Diabetes: Response to Brand-Miller et al. and Mann

Errata